ARGX argenx SE
ARGX argenx SE
Healthcare · Biotechnology
Desk view
Market read
POC $824.50 · VWAP $850.00 · +2.8% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
ARGX Price Structure
Loading timeframes…
Peers
Every watchlist ARGX belongs to, members best 30-day change first — ARGX highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@ibb
@focus
Reported EPS $7.80 versus an analyst consensus of $-27.83, which is out of line with the company's earlier estimates (a one-time item or a provider error), so no beat or miss is graded.
full note →Against street estimates
How ARGX's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about ARGX from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled today · Oct 23
- argenx SE (ARGX.BR) Stock Price, News, Quote & History - Yahoo Finance
- Newsroom
- Earnings call transcript: argenx tops revenue forecasts in Q3 2026 on strong growth By Investing.com
- argenx Reports Third Quarter 2026 Financial Results and
- argenx Q3 profit rises to $506M as sales gain 54% | ARGX SEC Filing - Form 6-K
- argenx SE (ARGX) Stock Price & Overview
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
ARGX research tape
48 dated scans, research, and events, newest first — the full record.